In plain English
Novo Nordisk A/S develops and sells medicines for diabetes, obesity, and related conditions, with a focus on GLP‑1 drugs like Ozempic and…
Equity · NYSE · DKK
NVO
Novo Nordisk A/S
$38.52
Today
−$0.88-2.23%
vs previous close
Quote
- Open
- $39.15
- High
- $39.15
- Low
- $38.43
- Prev close
- $39.40
- Sector
- Other
- Industry
- Pharmaceuticals
- Size
- Large-cap
- Market cap
- $1.15T
- Shares out
- 3.39B
- Country
- DK
- IPO
- May 17, 1974
- Exchange
- NYSE
- Website
- novonordisk.com
Price chart Pro
Loading chart…
Loading chart…
Company briefing
What NVO is
Plain English context — why the name shows up in the news, and what to watch next. Not a tip.
Latest on this name
Insights & deeper context
3 recent cards — open any for the full deeper dive.
Congressman Ditches Magnificent Seven Stocks for Consumer Staples: Here's What He Bought
In brief
Franklin is pivoting from tech to consumer staples, hinting he sees better upside in stable‑income businesses as inflation pressures ease.
Novo Nordisk, Anthropic Team Up For AI Drug Research
In brief
Novo Nordisk’s new AI partnership with Anthropic could accelerate drug discovery and strengthen its competitive position in biopharma.
Ozempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients
In brief
Amazon Pharmacy's new program offers affordable access to weight-loss drugs for Medicare beneficiaries, potentially attracting more customers and establishing a relationship with patients.
Filings & reports
SEC and filing-linked cards
No filings tagged yet
Filing-linked cards for NVO will show up here when available.
Indexes like the S&P 500 are shown via liquid ETFs (e.g. SPY). Company profile and quotes use live market data when available.